Michael S. Weiss
2020 - TG Therapeutics
In 2020, Michael S. Weiss earned a total compensation of $32.5M as Chief Executive Officer and President at TG Therapeutics, a 156% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $233,153 |
---|---|
Salary | $1,392,470 |
Stock Awards | $30,871,615 |
Total | $32,497,238 |
Weiss received $30.9M in stock awards, accounting for 95% of the total pay in 2020.
Weiss also received $233.2K in non-equity incentive plan and $1.4M in salary.
Rankings
In 2020, Michael S. Weiss' compensation ranked 93rd out of 13,090 executives tracked by ExecPay. In other words, Weiss earned more than 99.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 93 | 99th |
Manufacturing | 21 | 100th |
Chemicals And Allied Products | 5 | 100th |
Drugs | 5 | 100th |
Pharmaceutical Preparations | 3 | 100th |
Weiss' colleagues
We found one more compensation record of an executive who worked with Michael S. Weiss at TG Therapeutics in 2020.
2020
Sean Power
TG Therapeutics